Food and Drug Administration, HHS.
Final rule; correction.
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 26, 2004 (69 FR 9120). The document included typographical and inadvertent errors. This document corrects those errors.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Philip L. Chao, Office of Policy and Planning (HF-23), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-0587.End Further Info End Preamble Start Supplemental Information
In FR Doc. 04-4249, appearing on page 9120 in the Federal Register of Thursday, February 26, 2004, the following corrections are made:Start Amendment Part
1. On page 9151, in the third column, the first sentence of the first full paragraph, is corrected to read “We estimate that the rule provides net benefits to society of $4.3 billion to $4.5 billion annually, depending on whether a discount rate of 3 percent or 7 percent is used.”End Amendment Part Start Amendment Part
2. On page 9167, in the first column, the first sentence under the heading “ P. Small Business Analysis and Discussion of Alternatives” is corrected to read “For the reasons cited in the following paragraphs, the agency certifies that the final rule will not have a significant economic impact on a substantial number of small entities.”End Amendment Part Start Signature
Dated: March 31, 2004.
Assistant Commissioner for Policy.
[FR Doc. 04-7815 Filed 4-6-04; 8:45 am]
BILLING CODE 4160-01-S